Processing

Please wait...

Settings

Settings

Goto Application

1. WO2019004321 - AGENT FOR PREVENTING AND/OR TREATING ALZHEIMER’S DISEASE

Publication Number WO/2019/004321
Publication Date 03.01.2019
International Application No. PCT/JP2018/024465
International Filing Date 27.06.2018
IPC
A61K 31/4985 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61P 25/28 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
CPC
A61K 31/48
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
48Ergoline derivatives, e.g. lysergic acid, ergotamine
A61K 31/4985
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61P 25/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applicants
  • 国立大学法人京都大学 KYOTO UNIVERSITY [JP]/[JP]
Inventors
  • 井上 治久 INOUE, Haruhisa
  • 近藤 孝之 KONDO, Takayuki
Agents
  • 高島 一 TAKASHIMA, Hajime
  • 鎌田 光宜 KAMADA, Mitsunori
Priority Data
2017-12680828.06.2017JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) AGENT FOR PREVENTING AND/OR TREATING ALZHEIMER’S DISEASE
(FR) AGENT POUR LA PRÉVENTION ET/OU LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
(JA) アルツハイマー病の予防及び/又は治療剤
Abstract
(EN)
The present invention provides an agent for preventing and/or treatment Alzheimer's disease, the agent containing a compound represented by formula (I) or formula (II) or a salt thereof. The symbols in formula (I) and formula (II) are as described in the accompanying specification.
(FR)
La présente invention concerne un agent pour prévenir et/ou traiter la maladie d'Alzheimer, l'agent contenant un composé représenté par la formule (I) ou la formule (II) ou un sel de celui-ci. Les symboles dans la formule (I) et la formule (II) sont tels que décrits dans la description.
(JA)
本発明は、式(I)又は式(II)で表される化合物またはその塩を含有してなる、アルツハイマー病の予防及び/又は治療剤を提供する。式(I)及び(II)中各記号は添付の明細書に記載の通りである。
Latest bibliographic data on file with the International Bureau